Regulation of matrix metalloproteinase-9 (MMP-9) by translational efficiency in murine prostate carcinoma cells
- PMID: 11912173
Regulation of matrix metalloproteinase-9 (MMP-9) by translational efficiency in murine prostate carcinoma cells
Abstract
Expression of increased levels of matrix metalloproteinase-9 (MMP-9) has been implicated in tumor progression and angiogenesis. Much of our knowledge of the controls of MMP-9 levels has focused on transcription. Here we show that MMP-9 levels are also controlled by translational efficiency in murine prostate carcinoma cells. The murine prostate carcinoma cells 148-1,LMD and 148-1,PA were derived from a single mouse that had been implanted with urogenital sinus transformed by ras and myc. 148-1,PA secretes little MMP-9 yet has equivalent amounts of MMP-9 mRNA as the cell line 148-1,LMD that secretes substantially more. Infection with a retroviral vector for murine MMP-9 led to more expression of MMP-9 in both cases, but the differential remained. Human MMP-9 is equally expressed in both cells after infection with a vector for human MMP-9 indicating that the effect is species-specific. Pulse chase analysis revealed that MMP-9 was synthesized more rapidly in the 148-1,LMD cells than in the 148-1,PA cells. Markedly more MMP-9 mRNA was associated with polysomes in the cell line synthesizing more MMP-9. These results indicate regulation of MMP-9 synthesis at the level of translational efficiency.
Similar articles
-
Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.J Cell Physiol. 2002 May;191(2):208-16. doi: 10.1002/jcp.10092. J Cell Physiol. 2002. PMID: 12064464
-
Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancer.Anticancer Res. 2006 Mar-Apr;26(2A):973-82. Anticancer Res. 2006. PMID: 16619495
-
Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice.Gynecol Oncol. 2004 Dec;95(3):437-48. doi: 10.1016/j.ygyno.2004.08.032. Gynecol Oncol. 2004. PMID: 15581944
-
Hypoxia enhances gene expression of inducible nitric oxide synthase and matrix metalloproteinase-9 in ras/myc-transformed serum-free mouse embryo cells under simulated inflammatory and infectious conditions.Cell Biol Int. 2008 Aug;32(8):940-9. doi: 10.1016/j.cellbi.2008.04.008. Epub 2008 Apr 10. Cell Biol Int. 2008. PMID: 18474440
-
Matrix metalloproteinase 9 and prostate cancer risk: a meta-analysis of 1059 participants.Minerva Urol Nefrol. 2017 Aug;69(4):324-329. doi: 10.23736/S0393-2249.16.02623-0. Epub 2016 Jun 29. Minerva Urol Nefrol. 2017. PMID: 27355218 Review.
Cited by
-
RAS oncogenes: weaving a tumorigenic web.Nat Rev Cancer. 2011 Oct 13;11(11):761-74. doi: 10.1038/nrc3106. Nat Rev Cancer. 2011. PMID: 21993244 Free PMC article. Review.
-
Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression.Cancers (Basel). 2014 Jan 27;6(1):240-96. doi: 10.3390/cancers6010240. Cancers (Basel). 2014. PMID: 24473089 Free PMC article.
-
The multifunctional Ca2+/calmodulin-dependent kinase II regulates vascular smooth muscle migration through matrix metalloproteinase 9.Am J Physiol Heart Circ Physiol. 2012 May 15;302(10):H1953-64. doi: 10.1152/ajpheart.00978.2011. Epub 2012 Mar 16. Am J Physiol Heart Circ Physiol. 2012. PMID: 22427508 Free PMC article.
-
mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer.ISRN Otolaryngol. 2012 Oct 18;2012:953089. doi: 10.5402/2012/953089. Print 2012. ISRN Otolaryngol. 2012. PMID: 23762622 Free PMC article.
-
Novel MMP-9 substrates in cancer cells revealed by a label-free quantitative proteomics approach.Mol Cell Proteomics. 2008 Nov;7(11):2215-28. doi: 10.1074/mcp.M800095-MCP200. Epub 2008 Jul 2. Mol Cell Proteomics. 2008. PMID: 18596065 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous